Risk Mitigation for Pharmaceuticals and Life Science
Patient safety, clinical trial management, mergers and acquisitions, research and development, sales and marketing, and pricing structures are all areas where failure to conduct due diligence and mitigate risk effectively can lead to reputational damage, financial loss, and regulatory enforcement action. In just a couple of decades, the pharmaceuticals and life sciences industry has changed beyond recognition in response...